Eagle Strategies’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Eagle Strategies's LLY Position: Q3 2026 in Review
Eagle Strategies increased its Eli Lilly (LLY) stake by 0.52% in Q3 2026, buying an estimated $26K and bringing the position to 4,293 shares worth $4.97M. The position accounts for 0.48% of the portfolio, ranked #50.
Eagle Strategies first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.12M in Q2 2026. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Eagle Strategies held 4,293 shares of Eli Lilly worth $4.97M as of Q3 2026.
- Eagle Strategies bought 22 Eli Lilly shares in Q3 2026, an estimated $26K.
- Eli Lilly made up 0.48% of Eagle Strategies's portfolio in Q3 2026, its #50 holding.
- Eagle Strategies first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- Eagle Strategies's Eli Lilly position peaked at $5.12M in Q2 2026.
- 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Eagle Strategies's 13F filing for Q3 2026, filed 16 Oct 2026.